In a study examining the use of magic mushrooms in Canada, nearly 80% of respondents expressed their conviction that psilocybin, the active ingredient in these mushrooms, should be medically available for distressed patients. Notably, two-thirds of the Canadian participants in the same study concurred that such a therapy should be legally accessible for those who require it.
Going beyond merely advocating for its availability, a significant 84.8 percent of study participants believe that the public health system should bear the costs of psilocybin treatments. Many Canadians see psilocybin as a feasible treatment option, especially for alleviating end-of-life distress.
[toc]
Key Takeaways:
- Residents from Québec, Ontario, Alberta, and British Columbia view psilocybin as a legitimate medical alternative for dealing with end-of-life existential distress.
- Magic mushrooms are seen as a safe option for the treatment of existential distress.
- Participants in two double-blind studies reported immediate and sustained benefits, with effects persisting for six months or even longer.
Understanding Existential Distress
Existential distress, akin to existential suffering, spiritual distress, and demoralization, arises when individuals face their mortality. It can lead to feelings of helplessness, isolation, anxiety, and a loss of meaning and purpose in life. This particular type of distress profoundly affects patients with life-threatening illnesses, potentially resulting in a wish to hasten death or contemplate suicide.
Generally, people coping with terminal illnesses or significant life changes tend to experience this distress. It substantially impacts their mental health and overall quality of life.
Existential therapy aims to address issues such as anxiety, depression, grief, loneliness, apathy, despair, confusion about identity, feelings of purposelessness, and existential fear. While it can require multiple sessions, it may not be effective for everyone.
The questionable effectiveness of such therapy is a primary factor driving many individuals to explore alternative treatment options.
The Stance of Health Canada on Psilocybin as a Therapeutic Approach
Over the past two decades, preliminary clinical trials have highlighted the potential advantages of using psychedelic substances for the treatment of complex mental disorders. Specifically, psilocybin has been demonstrated to quickly and durably relieve existential distress in patients facing their final days.
Recognizing the possible efficacy of these proposed hallucinogenic mushrooms, especially where conventional treatments have not been successful, Health Canada revised the Special Access Program in 2022. This revision permits healthcare providers to request controlled substances for their patients.
Canadian Advocacy for Access to Psilocybin
A research article in the Palliative Care Journal investigates societal views on psilocybin-assisted therapy for end-of-life care. The data from this study includes:
| Methodology | Input from 2,800 Canadians from Québec, Ontario, Alberta, and British Columbia. 19% of these had previously used psilocybin (15% in Québec, 26% in British Columbia). |
| Findings | 79.3% view psilocybin-assisted therapy as a legitimate medical option for treating end-of-life existential distress. 63.3% believe psilocybin should be integrated into medical treatment. 84.8% endorse the public health system’s provision of this therapy. 44.2% think healthcare professionals should administer the substance without Health Canada’s supervision. |
These findings align with surveys from Canada, England, and Australia. The research team highlighted the uniqueness of their study in focusing on the use of psychoactive substances for treating existential distress in end-of-life situations.
Why Canadians Support the Use of Psilocybin
More Canadians are advocating for the application of psilocybin as a treatment, mainly due to evidence from reputable research institutions. An additional factor is the perceived safety of psilocybin mushrooms in relieving existential distress. Subjects across numerous studies have not reported severe adverse health effects, such as failure of multiple organs.
| Study | Approach | Outcomes |
| Johns Hopkins Study | 51 patients received a high dose of psilocybin and a low dose as an active placebo control | Rapid and enduring The reported benefits of the therapy can last up to six months or even more. The effectiveness is primarily due to mystical experiences that bring about a sense of unity and deep emotional insights. |
| Trial at New York University | Twenty-nine patients were randomly chosen to either receive psilocybin or the active placebo, niacin. | The results of the study were consistent with the Johns Hopkins study. Participants that were administered psilocybin reported psychological comfort and a better outlook on life and death. |
| BMC Palliative Care Study | Interviews were conducted with nineteen participants which included 7 doctors, 4 active nurses, 4 chaplains, 3 social workers, and a psychologist. The study aimed to understand the perception of palliative care professionals towards existential distress and their views on psychedelic therapy as a treatment option. | Palliative care practitioners indicated that psychedelic-assisted therapy (PAT) could potentially alleviate existential distress. |
Patient Experiences
Besides scientific research, there are numerous patient stories that validate the effectiveness of psilocybin. These narratives highlight its potential to improve mental health and overall quality of life.
The Journey of Yokoi
Mio Yokoi, who is battling terminal stage 4 pancreatic cancer, shares her enlightening experience during her assisted therapy. She compares her experience to being on a raft surrounded by nature and whimsical creatures. This vision imparts in her a profound understanding of the universe’s interconnectedness and support, providing immense peace and validation.
Despite availing traditional mental health support, Yokoi continued to experience severe anxiety and distress following her diagnosis. Psilocybin therapy helped her rebuild a connection with her body and provided a tangible feeling of love and support. This significantly improved her emotional and mental health.
Story of Chrissy
Chrissy, a woman in her 50s, was diagnosed with stage 4 breast cancer that had metastasized to her lungs. She was working full-time as an administrative supervisor in healthcare when the study took place and considered herself an atheist. She was diagnosed with Generalized Anxiety Disorder during her screening.
Chrissy reported significant decreases in her anxiety, depression, fear of death, hopelessness, and demoralization levels. When asked about any changes in her religious or spiritual beliefs since her therapy session, she stated that the experiences added substance and validity to her beliefs.
Brenda’s Journey
In the course of her therapy, Brenda underwent the sensation of dying twice. After these sessions, she no longer feared death, instead perceiving it as a natural phase of the life cycle. She recognized the study as the catalyst for her recovery journey from past childhood trauma, a change clearly reflected in her data.
Notable observations include a reduction in her anxiety and fear of death, along with an increase in her spirituality.
Assortment of Magic Mushroom Products Available in Canada
At present, there might be limitations on the accessibility of psilocybin capsules and other products aimed at managing existential distress or other mental health disorders. Nonetheless, reliable online dispensaries serve as a viable source for acquiring these products when necessary.
| Properties | Brazilian Psilocybe Cubensis | Cambodian Psilocybe Cubensis | Melmac Psilocybe Cubensis |
| Origin | Native to Brazil and some adjacent South American regions. | Discovered in Cambodia, near the Angkor Wat Temple. | Linked to Penis Envy mushrooms, which became popular in the 1970s. |
| Potency | Moderate potency; suitable for beginners. | Similarly moderate potency; perfect for those starting out. | Highly potent; suggested for users with intermediate to advanced experience. |
| Effects | Generates a mental buzz, mild disorientation, enhanced color discernment, euphoria, spiritual experiences, increased creativity, and better focus. | Induces an energizing and enduring high, subtle visual changes, enhanced creativity, euphoria, a mild physical high, fractal imagery, and feelings of joy. | Provokes profound shamanic experiences, vision quests, intense mystical experiences, enhanced creativity, focus, social awareness, and mood improvement. |
Ease End-of-life Discomfort with Psilocybin Products
The mental and emotional strain of existential or end-of-life distress can be overwhelming for many patients nearing the end of their lives. Conventional treatments can sometimes prove inadequate, leading to a surge in support within Canada for greater accessibility to magic mushrooms in public healthcare. This growing public advocacy could We advocate for regulatory authorities to recognize magic mushrooms as a legitimate treatment option. Obtain your psychedelics and mushroom delivery from Buy Dmt Canada.
Frequently Asked Questions
What should patients expect during Psilocybin-Assisted Therapy?
The experience of Psychedelic-assisted therapy (PAT) can differ significantly among patients, and to ensure a positive outcome, careful preparation and following prescribed procedures are crucial. Patients must undergo comprehensive screening and mental readiness exercises before ingesting the substance.
- Prior Session Preparation: Prior to the session, patients undergo an exhaustive assessment. The therapist will discuss the patient’s goals and expectations, setting clear intentions for the session. The therapist will also explain the potential effects and what the patient can expect during the session.
- The Session Itself: During the session, patients are given a controlled dose of the substance in a serene, distraction-free environment to promote relaxation and self-reflection. The therapist remains present throughout to offer continuous support and guidance.
- Post-Session Integration Therapy: This therapy helps patients comprehend and process their experiences. The following sessions provide ongoing support and counseling to reinforce the insights and changes achieved during therapy.
How does psilocybin affect the brains of individuals dealing with distress?
Psilocybin interacts with the brain by binding to serotonin receptors, particularly the 5-HT2A receptor. This interaction can cause alterations in perception, mood, and cognition, triggering significant shifts in consciousness, emotional revelations, and novel perspectives.
Is psilocybin therapy available to everyone?
Not everyone is a suitable candidate for psilocybin therapy. Individuals with certain mental health disorders or existential distress must undergo rigorous screening to eliminate those with prior records of psychosis.
Related Readings:
